In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)

The in vitro activity of ceftazidime in combination with NXL104 versus 470 Pseudomonas aeruginosa clinical isolates was evaluated using Clinical and Laboratory Standards Institute (CLSI) broth microdilution methods. Ceftazidime had MIC(90)s of 8 μg/ml and 32 μg/ml in the presence and absence of NXL1...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Walkty, A., DeCorby, M., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2011
Témata:
Susceptibility
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101411/
https://ncbi.nlm.nih.gov/pubmed/21422208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01696-10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky